Cisplatin synergizes immune checkpoint blocking through RNFT1 mediated PD-L1 recycling in Triple Negative Breast Cancer

被引：0
|
作者：
Chu, Jiahui
Zhang, Yifan
Hua, Yijia
Gong, Jue
Mei, Jie
Fu, Ziyi
Yi, Yongmei
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO3-24-03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO3-24-03
引用
收藏
页数：2
相关论文
共 50 条
  • [41] JAK2 and PD-L1 Amplification Enhance the Dynamic Expression of PD-L1 in Triple-negative Breast Cancer
    Chen, Meixuan
    Pockaj, Barbara
    Andreozzi, Mariacarla
    Barrett, Michael T.
    Krishna, Sri
    Eaton, Seron
    Niu, Ruifang
    Anderson, Karen S.
    CLINICAL BREAST CANCER, 2018, 18 (05) : E1205 - E1215
  • [42] Future of PD-1/PD-L1 axis modulation for the treatment of triple-negative breast cancer
    Nakhjavani, Maryam
    Shigdar, Sarah
    PHARMACOLOGICAL RESEARCH, 2022, 175
  • [43] PD-1/PD-L1 immune checkpoint: Potential target for cancer therapy
    Dermani, Fatemeh K.
    Samadi, Pouria
    Rahmani, Golebagh
    Kohlan, Alisa K.
    Najafi, Rezvan
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (02) : 1313 - 1325
  • [44] Immunohistochemistry of Immune Checkpoint Markers PD-1 and PD-L1 in Prostate Cancer
    Sharma, Meenal
    Yang, Qi
    Mcmahon, Loralee
    Miyamoto, Hiroshi
    MODERN PATHOLOGY, 2019, 32
  • [45] Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer
    Iosune Baraibar
    Ignacio Melero
    Mariano Ponz-Sarvise
    Eduardo Castanon
    Drug Safety, 2019, 42 : 281 - 294
  • [46] Immunohistochemistry of Immune Checkpoint Markers PD-1 and PD-L1 in Prostate Cancer
    Sharma, Meenal
    Yang, Qi
    Mcmahon, Loralee
    Miyamoto, Hiroshi
    LABORATORY INVESTIGATION, 2019, 99
  • [47] Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer
    Baraibar, Iosune
    Melero, Ignacio
    Ponz-Sarvise, Mariano
    Castanon, Eduardo
    DRUG SAFETY, 2019, 42 (02) : 281 - 294
  • [48] Immunohistochemistry of immune checkpoint markers PD-1 and PD-L1 in prostate cancer
    Sharma, Meenal
    Yang, Zhiming
    Miyamoto, Hiroshi
    MEDICINE, 2019, 98 (38)
  • [49] Loss of RBMS1 promotes anti-tumor immunity through enabling PD-L1 checkpoint blockade in triple-negative breast cancer
    Jinrui Zhang
    Ge Zhang
    Wenjing Zhang
    Lu Bai
    Luning Wang
    Tiantian Li
    Li Yan
    Yang Xu
    Dan Chen
    Wenting Gao
    Chuanzhou Gao
    Chaoqun Chen
    Menglin Ren
    Yuexia Jiao
    Hongqiang Qin
    Yu Sun
    Lili Zhi
    Yangfan Qi
    Jinyao Zhao
    Quentin Liu
    Han Liu
    Yang Wang
    Cell Death & Differentiation, 2022, 29 : 2247 - 2261
  • [50] Loss of RBMS1 promotes anti-tumor immunity through enabling PD-L1 checkpoint blockade in triple-negative breast cancer
    Zhang, Jinrui
    Zhang, Ge
    Zhang, Wenjing
    Bai, Lu
    Wang, Luning
    Li, Tiantian
    Yan, Li
    Xu, Yang
    Chen, Dan
    Gao, Wenting
    Gao, Chuanzhou
    Chen, Chaoqun
    Ren, Menglin
    Jiao, Yuexia
    Qin, Hongqiang
    Sun, Yu
    Zhi, Lili
    Qi, Yangfan
    Zhao, Jinyao
    Liu, Quentin
    Liu, Han
    Wang, Yang
    CELL DEATH AND DIFFERENTIATION, 2022, 29 (11): : 2247 - 2261
12345